Vic Kanuf, Ph.D.

Chariman of the Scientific Advisory Board

​

Dr. Knauf served as Arcadia Biosciences' Chief Scientific Officer from 2005 until his retirement at the end of 2016. 

​

In 1983, he joined Calgene, a plant biotechnology pioneering company, as a Principal Scientist to develop research programs focused on improving the lipid composition and content of oilseed crops. He was serving as Calgene's Vice President of Research at the time of acquisition by Monsanto in 1997.

 

After managing a set of research programs within Monsanto's Food and Nutrition Sector, Knauf left in 2000 to be a Co-founder, Director, and Chief Technical Officer of Tilligen, a crop biotechnology company focused on applications of novel non-GM methodologies originally developed at the Fred Hutchinson Cancer Research Center in Seattle. Tilligen, later renamed Anawah, was acquired by Arcadia Biosciences in 2005.
 

Knauf has been an author of more than 50 scientific publications and an inventor of more than 30 issued U.S. patents, primarily in the area of modified plant lipids and crop improvement technologies.

​

He received a B.S. in Biology from the New Mexico Institute of Mining and Technology, and M.S. and Ph.D. in microbiology and immunology from the University of Washington.

​